These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2745687)

  • 1. Susceptibility of methicillin-resistant Staphylococcus aureus to lysostaphin.
    Huber MM; Huber TW
    J Clin Microbiol; 1989 May; 27(5):1122-4. PubMed ID: 2745687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW; Patron RL; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between methicillin resistance and susceptibility to lysostaphin in Staphylococcus aureus.
    Chopra I; Lacey RW
    J Gen Microbiol; 1974 Jun; 82(2):419-20. PubMed ID: 4496819
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
    Polak J; Della Latta P; Blackburn P
    Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
    LaPlante KL
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.
    Shalit I; Berger SA; Gorea A; Frimerman H
    Antimicrob Agents Chemother; 1989 Apr; 33(4):593-4. PubMed ID: 2729953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood.
    von Eiff C; Kokai-Kun JF; Becker K; Peters G
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3613-5. PubMed ID: 14576128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
    Dajcs JJ; Thibodeaux BA; Hume EB; Zheng X; Sloop GD; O'Callaghan RJ
    Curr Eye Res; 2001 Jun; 22(6):451-7. PubMed ID: 11584345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin resistant Staphylococcus aureus.
    Cooke EM; Marples RR
    Br Med J (Clin Res Ed); 1987 Feb; 294(6568):371. PubMed ID: 3101881
    [No Abstract]   [Full Text] [Related]  

  • 11. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.
    Yang XY; Li CR; Lou RH; Wang YM; Zhang WX; Chen HZ; Huang QS; Han YX; Jiang JD; You XF
    J Med Microbiol; 2007 Jan; 56(Pt 1):71-76. PubMed ID: 17172520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
    Shah A; Mond J; Walsh S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections.
    McMurray LW; Kernodle DS; Barg NL
    J Infect Dis; 1990 Sep; 162(3):759-62. PubMed ID: 2388000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Staphylococcal bacteremia. 1. Bacteremia due to methicillin-cephem resistant Staphylococcus aureus].
    Shimada K; Oka S; Suzuki H; Inamatsu T; Urayama K
    Kansenshogaku Zasshi; 1985 May; 59(5):459-63. PubMed ID: 3932532
    [No Abstract]   [Full Text] [Related]  

  • 17. Methicillin-resistant Staphylococcus aureus.
    J Hosp Infect; 1983 Dec; 4(4):327-9. PubMed ID: 6198361
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Alvarez S; Jones M; Berk SL
    Antimicrob Agents Chemother; 1985 Nov; 28(5):689-90. PubMed ID: 3853963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Staphylococcus aureus resistant to methicillin].
    Rietra PJ
    Ned Tijdschr Geneeskd; 1988 Feb; 132(9):381-3. PubMed ID: 3347310
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes.
    Qoronfleh MW; Wilkinson BJ
    Antimicrob Agents Chemother; 1986 Feb; 29(2):250-7. PubMed ID: 2872855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.